U.S. Botulinum Toxin Market to Reach USD 6.58 Billion by 2033 as Minimally Invasive Aesthetic and Therapeutic Demand Expands
The U.S. botulinum toxin market is entering a sustained growth phase, driven by the convergence of cosmetic enhancement and therapeutic innovation. What began primarily as an aesthetic anti-aging solution has evolved into a versatile clinical tool used across dermatology, neurology, … Read more